Optimizing vector design and delivery by enhancing specificity, durability, and safety for targeted gene expression

Navigating preclinical and clinical challenges by addressing immunogenicity, durability, and patient response variability

Understanding regulatory and market access considerations to overcome hurdles in approvals, pricing, and patient accessibility